tiprankstipranks
Trending News
More News >
Olympus Corp. (JP:7733)
:7733
Japanese Market

Olympus (7733) Stock Forecast & Price Target

Compare
6 Followers
See the Price Targets and Ratings of:

7733 Analyst Ratings

Moderate Buy
4Ratings
Moderate Buy
2 Buy
2 Hold
0 Sell
Based on 4 analysts giving stock ratings to
Olympus
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

7733 Stock 12 Month Forecast

Average Price Target

¥2,325.21
▲(20.32%Upside)
Based on 4 Wall Street analysts offering 12 month price targets for Olympus in the last 3 months. The average price target is ¥2,325.21 with a high forecast of ¥2,900.00 and a low forecast of ¥1,900.00. The average price target represents a 20.32% change from the last price of ¥1,932.50.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1839":"¥1,839","2370":"¥2,370","2901":"¥2,901","2104.5":"¥2,104.5","2635.5":"¥2,635.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":2900.000000043036,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">¥2.90K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2325.2103278558,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">¥2.33K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1900.000000028196,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">¥1.90K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1839,2104.5,2370,2635.5,2901],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2024","6":"Nov<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1840,1921.538461541772,2003.076923083544,2084.615384625316,2166.153846167088,2247.69230770886,2329.230769250632,2410.769230792404,2492.307692334176,2573.846153875948,2655.38461541772,2736.923076959492,2818.461538501264,{"y":2900.000000043036,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1840,1877.3238713735232,1914.647742747046,1951.9716141205693,1989.2954854940924,2026.6193568676154,2063.9432282411385,2101.2670996146617,2138.590970988185,2175.914842361708,2213.2387137352307,2250.562585108754,2287.886456482277,{"y":2325.2103278558,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1840,1844.6153846175534,1849.2307692351071,1853.8461538526606,1858.4615384702142,1863.0769230877677,1867.6923077053211,1872.3076923228748,1876.9230769404282,1881.5384615579817,1886.1538461755354,1890.7692307930888,1895.3846154106425,{"y":1900.000000028196,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2074.333,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2126.375,"date":1706745600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2163.345,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2517.301,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2529.182,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2740.567,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2638.092,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2320.769,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2343.541,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2026.712,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1925,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1906.5,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1840,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target¥2,900Average Price Target¥2,325Lowest Price Target¥1,900
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on JP:7733
TipRanks AITipRanks
Not Ranked
TipRanks
¥2,107
Buy
9.03%
Upside
Reiterated
06/04/25
Olympus's strong financial performance and strategic achievements, particularly in North America, drive a positive outlook. The mixed technical indicators and moderate valuation suggest some caution. Concerns from the earnings call, such as leadership changes and regional challenges, slightly offset the strengths.
Citi
¥3,000¥2,500
Buy
29.37%
Upside
Reiterated
06/02/25
Citi Remains a Buy on Olympus (OCPNF)
Nomura
¥2,200¥2,000
Hold
3.49%
Upside
Reiterated
05/22/25
Olympus Corporation (7733:JP) (OCPNY) PT Lowered to JPY2,000 at Nomura/InstinetNomura/Instinet analyst Takahiro Mori lowered the price target on Olympus Corporation (7733:JP) (OTC: OCPNY) to JPY2,000.00 (from JPY2,200.00) while maintaining a Neutral rating.
Jefferies
¥1,900
Hold
-1.68%
Downside
Downgraded
04/22/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Olympus (Other OTC: OCPNF) and Corvus Pharmaceuticals (NASDAQ: CRVS)
J.P. Morgan Analyst forecast on JP:7733
Naoko SaitoJ.P. Morgan
J.P. Morgan
¥3,100¥2,900
Buy
50.06%
Upside
Reiterated
03/24/25
Olympus Corporation (7733:JP) (OCPNY) PT Lowered to JPY2,900 at JPMorganJPMorgan analyst Naoko Saito lowered the price target on Olympus Corporation (7733:JP) (OTC: OCPNY) to JPY2,900.00 (from JPY3,100.00) while maintaining a Overweight rating.
Macquarie Analyst forecast on JP:7733
Tony RenMacquarie
Macquarie
¥3,400¥2,800
Buy
44.89%
Upside
Reiterated
03/05/25
Olympus Corporation (7733:JP) (OCPNY) PT Lowered to JPY2,800 at MacquarieMacquarie analyst Tony Ren lowered the price target on Olympus Corporation (7733:JP) (OTC: OCPNY) to JPY2,800.00 (from JPY3,400.00) while maintaining a Outperform rating.
Morgan Stanley Analyst forecast on JP:7733
Ryotaro HayashiMorgan Stanley
Morgan Stanley
¥3,200
Buy
65.59%
Upside
Reiterated
12/29/24
Morgan Stanley Reiterates Overweight Rating on Olympus Corporation (7733:JP) (OCPNY)Morgan Stanley analyst Ryotaro Hayashi reiterated an Overweight rating and JPY3,200.00 price target on Olympus Corporation (7733:JP) (OTC: OCPNY).
CLSA
¥2,700¥2,850
Buy
47.48%
Upside
Reiterated
11/13/24
Olympus Corporation (7733:JP) (OCPNY) PT Raised to JPY2,850 at CLSACLSA analyst Michael Luo raised the price target on Olympus Corporation (7733:JP) (OTC: OCPNY) to JPY2,850.00 (from JPY2,700.00) while maintaining a Outperform (2) rating.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on JP:7733
TipRanks AITipRanks
Not Ranked
TipRanks
¥2,107
Buy
9.03%
Upside
Reiterated
06/04/25
Olympus's strong financial performance and strategic achievements, particularly in North America, drive a positive outlook. The mixed technical indicators and moderate valuation suggest some caution. Concerns from the earnings call, such as leadership changes and regional challenges, slightly offset the strengths.
Citi
¥3,000¥2,500
Buy
29.37%
Upside
Reiterated
06/02/25
Citi Remains a Buy on Olympus (OCPNF)
Nomura
¥2,200¥2,000
Hold
3.49%
Upside
Reiterated
05/22/25
Olympus Corporation (7733:JP) (OCPNY) PT Lowered to JPY2,000 at Nomura/InstinetNomura/Instinet analyst Takahiro Mori lowered the price target on Olympus Corporation (7733:JP) (OTC: OCPNY) to JPY2,000.00 (from JPY2,200.00) while maintaining a Neutral rating.
Jefferies
¥1,900
Hold
-1.68%
Downside
Downgraded
04/22/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Olympus (Other OTC: OCPNF) and Corvus Pharmaceuticals (NASDAQ: CRVS)
J.P. Morgan Analyst forecast on JP:7733
Naoko SaitoJ.P. Morgan
J.P. Morgan
¥3,100¥2,900
Buy
50.06%
Upside
Reiterated
03/24/25
Olympus Corporation (7733:JP) (OCPNY) PT Lowered to JPY2,900 at JPMorganJPMorgan analyst Naoko Saito lowered the price target on Olympus Corporation (7733:JP) (OTC: OCPNY) to JPY2,900.00 (from JPY3,100.00) while maintaining a Overweight rating.
Macquarie Analyst forecast on JP:7733
Tony RenMacquarie
Macquarie
¥3,400¥2,800
Buy
44.89%
Upside
Reiterated
03/05/25
Olympus Corporation (7733:JP) (OCPNY) PT Lowered to JPY2,800 at MacquarieMacquarie analyst Tony Ren lowered the price target on Olympus Corporation (7733:JP) (OTC: OCPNY) to JPY2,800.00 (from JPY3,400.00) while maintaining a Outperform rating.
Morgan Stanley Analyst forecast on JP:7733
Ryotaro HayashiMorgan Stanley
Morgan Stanley
¥3,200
Buy
65.59%
Upside
Reiterated
12/29/24
Morgan Stanley Reiterates Overweight Rating on Olympus Corporation (7733:JP) (OCPNY)Morgan Stanley analyst Ryotaro Hayashi reiterated an Overweight rating and JPY3,200.00 price target on Olympus Corporation (7733:JP) (OTC: OCPNY).
CLSA
¥2,700¥2,850
Buy
47.48%
Upside
Reiterated
11/13/24
Olympus Corporation (7733:JP) (OCPNY) PT Raised to JPY2,850 at CLSACLSA analyst Michael Luo raised the price target on Olympus Corporation (7733:JP) (OTC: OCPNY) to JPY2,850.00 (from JPY2,700.00) while maintaining a Outperform (2) rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Olympus

1 Month
xxx
Success Rate
4/6 ratings generated profit
67%
Average Return
-0.28%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of -0.28% per trade.
3 Months
xxx
Success Rate
4/6 ratings generated profit
67%
Average Return
+5.28%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +5.28% per trade.
1 Year
Naoko SaitoJ.P. Morgan
Success Rate
2/6 ratings generated profit
33%
Average Return
-3.75%
reiterated a buy rating 3 months ago
Copying Naoko Saito's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -3.75% per trade.
2 Years
xxx
Success Rate
1/6 ratings generated profit
17%
Average Return
-13.18%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 16.67% of your transactions generating a profit, with an average return of -13.18% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

7733 Analyst Recommendation Trends

Rating
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
2
5
4
4
1
Buy
0
0
0
0
0
Hold
1
1
2
2
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
6
6
6
3
In the current month, 7733 has received 1 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. 7733 average Analyst price target in the past 3 months is 2,325.21.
Each month's total comprises the sum of three months' worth of ratings.

7733 Financial Forecast

7733 Earnings Forecast

Next quarter’s earnings estimate for 7733 is ¥16.89 with a range of ¥14.78 to ¥19.40. The previous quarter’s EPS was ¥36.56. 7733 beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.05% of the time in the same period. In the last calendar year 7733 has Outperformed its overall industry.
Next quarter’s earnings estimate for 7733 is ¥16.89 with a range of ¥14.78 to ¥19.40. The previous quarter’s EPS was ¥36.56. 7733 beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.05% of the time in the same period. In the last calendar year 7733 has Outperformed its overall industry.

7733 Sales Forecast

Next quarter’s sales forecast for 7733 is ¥229.41B with a range of ¥218.60B to ¥237.60B. The previous quarter’s sales results were ¥272.11B. 7733 beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 47.43% of the time in the same period. In the last calendar year 7733 has Outperformed its overall industry.
Next quarter’s sales forecast for 7733 is ¥229.41B with a range of ¥218.60B to ¥237.60B. The previous quarter’s sales results were ¥272.11B. 7733 beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 47.43% of the time in the same period. In the last calendar year 7733 has Outperformed its overall industry.

7733 Stock Forecast FAQ

What is JP:7733’s average 12-month price target, according to analysts?
Based on analyst ratings, Olympus Corp.’s 12-month average price target is 2,325.21.
    What is JP:7733’s upside potential, based on the analysts’ average price target?
    Olympus Corp. has 20.32% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Olympus Corp. a Buy, Sell or Hold?
          Olympus Corp. has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Olympus Corp.’s share price target?
            The average share price target for Olympus Corp. is 2,325.21. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is ¥2,900.00 ,and the lowest forecast is ¥1,900.00. The average share price target represents 20.32% Increase from the current price of ¥1,932.5.
              What do analysts say about Olympus Corp.?
              Olympus Corp.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 4 Wall Streets Analysts.
                How can I buy shares of Olympus Corp.?
                To buy shares of JP:7733, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis